abrdn Physical Palladium Shares ETF PALL

$23.84 -4.06% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q FORM 10-Q 2026-08-07 View →
8-K CURRENT REPORT 2026-05-18 View →
10-Q QUARTERLY REPORT 2026-05-08 View →
8-K CURRENT REPORT 2026-04-22 View →
10-K ANNUAL REPORT 2026-03-02 View →
10-Q QUARTERLY REPORT 2025-11-07 View →
10-Q QUARTERLY REPORT 2025-08-07 View →
10-Q QUARTERLY REPORT 2025-05-08 View →
10-K ANNUAL REPORT 2025-02-28 View →
10-Q QUARTERLY REPORT 2024-11-12 View →
8-K CURRENT REPORT 2024-08-14 View →
10-Q QUARTERLY REPORT 2024-08-09 View →
8-K CURRENT REPORT 2024-05-28 View →
10-Q QUARTERLY REPORT 2024-05-09 View →
10-K ANNUAL REPORT 2024-02-29 View →
10-Q QUARTERLY REPORT 2023-11-08 View →
10-Q QUARTERLY REPORT 2023-08-09 View →
S-3 REGISTRATION STATEMENT 2023-05-18 View →
10-Q QUARTERLY REPORT 2023-05-09 View →
10-K ANNUAL REPORT 2023-03-01 View →
10-Q QUARTERLY REPORT 2022-11-04 View →
10-Q QUARTERLY REPORT 2022-08-05 View →
10-Q QUARTERLY REPORT 2022-05-09 View →
8-K CURRENT REPORT 2022-03-14 View →
10-K ANNUAL REPORT 2022-03-01 View →
10-Q QUARTERLY REPORT 2021-11-05 View →
10-Q QUARTERLY REPORT 2021-08-06 View →
8-K CURRENT REPORT 2021-07-01 View →
10-Q QUARTERLY REPORT 2021-05-07 View →
10-K ANNUAL REPORT 2021-03-01 View →
10-Q QUARTERLY REPORT 2020-11-06 View →
10-Q QUARTERLY REPORT 2020-08-07 View →
S-3 REGISTRATIONN STATEMENT 2020-05-08 View →
10-Q 10-Q 2020-05-08 View →
10-K 10-K 2020-02-28 View →
10-Q 10-Q 2019-11-08 View →
10-Q 10-Q 2019-08-09 View →
10-Q 10-Q 2019-05-09 View →
8-K CURRENT REPORT 2019-04-01 View →
10-K 10-K 2019-02-28 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$23.84
Market Cap
$648.15 million
52-Week Range
$19.70 $39.48
Average Volume
696K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.